Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F D Verbraak

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Ophthalmic Paediatrics and Genetics|September 1, 1992
Congenital glaucoma in a child with partial 1q duplication and 9p deletionF D Verbraak, K Pogány, J W Pilon, et al.
AIDS (London, England)|June 10, 1998
Cytomegalovirus (CMV) strain differences between the eye and blood in AIDS patients with CMV retinitisF D Verbraak, M Bruinenberg, G J van den Horn, et al.
Translational Vision Science & Technology|March 12, 2024
Perspectives of Patients and Professionals on Implementing a Computer Adaptive Vision-Related Quality of Life Outcome (CAT-EyeQ) in Clinical PracticeT P Rausch-Koster, H P A van der Aa, F D Verbraak, et al.
Lasers in Medical Science|May 3, 2005
Optical coherence tomography of the Ex-PRESS miniature glaucoma implantF D Verbraak, D M de Bruin, M Sulak, et al.
Ophthalmology and Therapy|June 15, 2025
Real-World 5-Year Outcomes of Age-Related Macular Degeneration with Bevacizumab as First-Line Anti-VEGFH Mhmud, J P Vermeulen, O A M Tigchelaar-Besling, et al.
The British Journal of Ophthalmology|January 30, 1999
Risk of developing CMV retinitis following non-ocular CMV end organ disease in AIDS patientsF D Verbraak, G J van den Horn, J T van der Meer, et al.
Journal of Patient-Reported Outcomes|January 6, 2021
Translation and content validity of the Dutch Impact of Vision Impairment questionnaire assessed by Three-Step Test-InterviewingT P Rausch-Koster, A J van der Ham, C B Terwee, et al.
Plos One|May 21, 2016
Comparing the Effectiveness of Bevacizumab to Ranibizumab in Patients with Exudative Age-Related Macular Degeneration. The BRAMD StudyA M E Schauwvlieghe, G Dijkman, J M Hooymans, et al.
BMC Ophthalmology|July 8, 2015
Comparing the effectiveness and costs of Bevacizumab to Ranibizumab in patients with Diabetic Macular Edema: a randomized clinical trial (the BRDME study)A M E Schauwvlieghe, G Dijkman, J M Hooymans, et al.
Seminars in Arthritis and Rheumatism|September 24, 2020
Microvascular changes of the retina in ankylosing spondylitis, and the association with cardiovascular disease - the eye for a heart studyR E van Bentum, M Baniaamam, B Kinaci-Tas, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Ophthalmic Paediatrics and Genetics|September 1, 1992
Congenital glaucoma in a child with partial 1q duplication and 9p deletionF D Verbraak, K Pogány, J W Pilon, et al.
AIDS (London, England)|June 10, 1998
Cytomegalovirus (CMV) strain differences between the eye and blood in AIDS patients with CMV retinitisF D Verbraak, M Bruinenberg, G J van den Horn, et al.
Translational Vision Science & Technology|March 12, 2024
Perspectives of Patients and Professionals on Implementing a Computer Adaptive Vision-Related Quality of Life Outcome (CAT-EyeQ) in Clinical PracticeT P Rausch-Koster, H P A van der Aa, F D Verbraak, et al.
Lasers in Medical Science|May 3, 2005
Optical coherence tomography of the Ex-PRESS miniature glaucoma implantF D Verbraak, D M de Bruin, M Sulak, et al.
Ophthalmology and Therapy|June 15, 2025
Real-World 5-Year Outcomes of Age-Related Macular Degeneration with Bevacizumab as First-Line Anti-VEGFH Mhmud, J P Vermeulen, O A M Tigchelaar-Besling, et al.
The British Journal of Ophthalmology|January 30, 1999
Risk of developing CMV retinitis following non-ocular CMV end organ disease in AIDS patientsF D Verbraak, G J van den Horn, J T van der Meer, et al.
Journal of Patient-Reported Outcomes|January 6, 2021
Translation and content validity of the Dutch Impact of Vision Impairment questionnaire assessed by Three-Step Test-InterviewingT P Rausch-Koster, A J van der Ham, C B Terwee, et al.
Plos One|May 21, 2016
Comparing the Effectiveness of Bevacizumab to Ranibizumab in Patients with Exudative Age-Related Macular Degeneration. The BRAMD StudyA M E Schauwvlieghe, G Dijkman, J M Hooymans, et al.
BMC Ophthalmology|July 8, 2015
Comparing the effectiveness and costs of Bevacizumab to Ranibizumab in patients with Diabetic Macular Edema: a randomized clinical trial (the BRDME study)A M E Schauwvlieghe, G Dijkman, J M Hooymans, et al.
Seminars in Arthritis and Rheumatism|September 24, 2020
Microvascular changes of the retina in ankylosing spondylitis, and the association with cardiovascular disease - the eye for a heart studyR E van Bentum, M Baniaamam, B Kinaci-Tas, et al.
Pageof 4